%0 Journal Article
%T Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer
%A Alexia Savignoni
%A Francois-Clement Bidard
%A Fr¨¦derique Berger
%A Jean-Yves Pierga
%A Luc Cabel
%A Marie-Laure Tanguy
%J Archive of "NPJ Breast Cancer".
%D 2018
%R 10.1038/s41523-018-0068-4
%X Summary of trial characteristics and result
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018749/